Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
System and method for optimizing teams
Semiconductor device
Method of allocating IP address of image forming apparatus using DHCP, image forming apparatus and system of allocating IP address using DHCP
Systems and methods for synchronizing and controlling multiple image sensors
Front cover of an electronic device
Liquid dispensing apparatus
Lubricant coating device and image forming apparatus
  Randomly Featured Patents
Adjustable lamp
Method and apparatus for automated biopsy and collection of soft tissue
Lift installation with primary and secondary transmitter receiver means
Collapsible bed-pan support for invalids
Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
Radiation-sensitive resin composition
Phosphoric acid ester, process for preparing the same, and detergent composition containing the same
Toy stove
Registration of optical images of turbid media